JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

Cencora Inc

Отворен

СекторЗдравеопазване

305.12 -2.07

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

298.7

Максимум

312.67

Ключови измерители

By Trading Economics

Приходи

906M

566M

Продажби

2.2B

86B

P/E

Средно за сектора

37.19

67.147

EPS

4.08

Дивидентна доходност

0.73

Марж на печалбата

0.659

Служители

47,000

EBITDA

858M

1B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+29.04% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.73%

2.36%

Следващи печалби

6.05.2026 г.

Следваща дата на дивидент

1.06.2026 г.

Следваща дата на екс-дивидент

15.05.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-10B

60B

Предишно отваряне

307.19

Предишно затваряне

305.12

Настроения в новините

By Acuity

7%

93%

6 / 348 Класиране в Healthcare

Cencora Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.04.2026 г., 23:53 ч. UTC

Печалби

Naver Posts Weaker First-Quarter Earnings

29.04.2026 г., 23:41 ч. UTC

Горещи акции

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29.04.2026 г., 23:55 ч. UTC

Печалби

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29.04.2026 г., 23:54 ч. UTC

Печалби

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29.04.2026 г., 23:52 ч. UTC

Печалби

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Печалби

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29.04.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan 1Q Net CNY1.70B, Down 14%

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan: Power Generation Down 2.9% as of End-March

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss Narrows>000002.SZ

29.04.2026 г., 23:18 ч. UTC

Печалби

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29.04.2026 г., 23:17 ч. UTC

Печалби

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29.04.2026 г., 23:13 ч. UTC

Печалби

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29.04.2026 г., 23:12 ч. UTC

Печалби

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29.04.2026 г., 23:04 ч. UTC

Печалби

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29.04.2026 г., 23:04 ч. UTC

Печалби

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Сравнение с други в отрасъла

Ценова промяна

Cencora Inc Прогноза

Ценова цел

By TipRanks

29.04% нагоре

12-месечна прогноза

Среден 401.86 USD  29.04%

Висок 429 USD

Нисък 360 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Cencora Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

6

Купи

2

Задържане

0

Продай

Настроение

By Acuity

6 / 348 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat